Premium
Supernus Pharmaceuticals Inc (0LB2)
LSE
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | 36.613 | 15.608 | 15.83 | 10.575 | 9.529 | 3.346 | 3.58 | 0.088 |
| Return on Equity (%) | 58.733 | 24.948 | 30.81 | 21.566 | 18.944 | 6.846 | 7.134 | 0.146 |
| Return on Invested Capital (%) | 148.552 | 73.761 | 53.99 | 36.72 | 34.202 | 16.128 | 10.109 | 8.464 |
| Operating Margin (%) | 25.795 | 33.81 | 38.711 | 43.333 | 36.972 | 16.661 | 10.163 | 0.853 |
| Net Profit Margin (%) | 42.428 | 18.953 | 27.144 | 28.785 | 24.395 | 9.215 | 9.099 | 0.217 |
| Book Value Per Share | 3.507 | 4.511 | 8.06 | 10.862 | 5.724 | -1.622 | 1.23 | 3.745 |
| Earnings Per Share | 1.825 | 1.116 | 2.122 | 2.152 | 2.401 | 1.003 | 1.119 | 0.024 |
| Cash Per Share | 1.329 | 1.955 | 3.675 | 3.453 | 5.46 | 3.82 | 1.716 | 1.374 |
| Working Capital Per Share | 1.414 | 2.055 | 6.348 | 5.94 | 7.288 | 5.374 | 0.851 | 3.714 |
| Operating Profit Per Share | 4.111 | 5.751 | 7.658 | 7.286 | 8.932 | 9.649 | 10.754 | 9.66 |
| EBIT Per Share | 1.008 | 1.961 | 2.679 | 2.808 | 3.19 | 1.374 | 1.12 | 0.051 |
| EBITDA Per Share | 1.008 | 1.961 | 2.679 | 2.808 | 3.19 | 1.374 | 1.12 | 0.051 |
| Free Cash Flow Per Share | 2.186 | 1.215 | 2.017 | 2.077 | 2.088 | 0.43 | -0.45 | -1.519 |
| Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Actions en circulation | 49,97M | 51,32M | 52,32M | 52,53M | 52,87M | 53,26M | 54,25M | N/A |
| Capitalisation boursière | 3B |
| Ratio cours/bénéfice | 1,59k |
| Ratio prix/ventes | 3,45 |
| Ratio prix/liquidités | 27,96 |
| Ratio prix/valeur comptable | 2,28 |
| Rendement de dividende | - |
| Actions en circulation | 54,63M |
| Volume moyen (1 semaine) | 528 |
| Volume moyen (1 mois) | 267 |
| Variation sur 52 semaines | 0,00% |
| Plus haut sur 52 semaines | 55,00 |
| Plus bas sur 52 semaines | 55,00 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
